未登录

C

Christine Blasey

Stanford University

H指数:47

被引数:8,876

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Attenuation of antidepressant and antisuicidal effects of ketamine by opioid receptor antagonism

MOLECULAR PSYCHIATRY

IF10.1

2019-08-2999

PREAI

Attenuation of Anti-Suicidal Effects of Ketamine by Opioid Receptor Antagonism

BIOLOGICAL PSYCHIATRY

IF9

2019-05-010

PREAI

Rigorous Translational Models Are Key to Studying Ketamine's Antidepressant Mechanism: Response to Wang and Kaplin

AMERICAN JOURNAL OF PSYCHIATRY

IF14.7

2019-05-011

OAAI

Interpreting Ketamine's Opioid Receptor Dependent Effect: Response to Sanacora

AMERICAN JOURNAL OF PSYCHIATRY

IF14.7

2019-03-017

OAAI

Target Population, Dose, and Timing Considerations for Understanding Naltrexone's Subjective Effect: Response to Amiaz

AMERICAN JOURNAL OF PSYCHIATRY

IF14.7

2019-03-012

OAAI

Attenuation of Antidepressant Effects of Ketamine by Opioid Receptor Antagonism

阿片受体拮抗作用减弱氯胺酮的抗抑郁作用

AMERICAN JOURNAL OF PSYCHIATRY

IF14.7

2018-12-01313

OAAI

Anxiety and Related Disorders and Concealment in Sexual Minority Young Adults

BEHAVIOR THERAPY

IF3.8

2016-01-01114

OAAI

Depression Subtypes in Predicting Antidepressant Response: A Report From the iSPOT-D Trial

AMERICAN JOURNAL OF PSYCHIATRY

IF14.7

2015-08-01133

PREAI

Low Circulating 25-Hydroxyvitamin D Concentrations Are Associated with Defects in Insulin Action and Insulin Secretion in Persons with Prediabetes

JOURNAL OF NUTRITION

IF3.8

2015-04-0142

OAAI

Magnetic Resonance Imaging Measures of Brain Structure to Predict Antidepressant Treatment Outcome in Major Depressive Disorder

IF10.8

2015-01-0159

OAAI

Cognitive Testing to Identify Children With ADHD Who Do and Do Not Respond to Methylphenidate

JOURNAL OF ATTENTION DISORDERS

IF2.2

2014-08-1318

OAAI

Buprenorphine implants for treatment of opioid dependence: randomized comparison to placebo and sublingual buprenorphine/naloxone

IF5.3

2013-09-1884

OAAI

Cardiometabolic risk factors and obesity: does it matter whether BMI or waist circumference is the index of obesity?

AMERICAN JOURNAL OF CLINICAL NUTRITION

IF6.9

2013-09-0161

OAAI

Beyond fasting plasma glucose: The association between coronary heart disease risk and postprandial glucose, postprandial insulin and insulin resistance in healthy, nondiabetic adults

METABOLISM-CLINICAL AND EXPERIMENTAL

IF11.9

2013-09-0118

PREAI

Administration of a selective glucocorticoid antagonist attenuates electroconvulsive shock-induced retrograde amnesia

JOURNAL OF NEURAL TRANSMISSION

IF4

2011-09-1620

PREAI

Catastrophizing, depression and pain-related disability

GENERAL HOSPITAL PSYCHIATRY

IF3.7

2011-03-0195

PREAI

Selective glucocorticoid receptor (type II) antagonists prevent weight gain caused by olanzapine in rats

EUROPEAN JOURNAL OF PHARMACOLOGY

IF4.7

2011-03-0118

PREAI

Preliminary evidence that plasma oxytocin levels are elevated in major depression

PSYCHIATRY RESEARCH

IF3.9

2010-07-01159

OAAI

Selective glucocorticoid receptor (type II) antagonist prevents and reverses olanzapine-induced weight gain

DIABETES OBESITY & METABOLISM

IF5.7

2010-04-2025

OAAI

Mifepristone treatment of olanzapine-induced weight gain in healthy men

ADVANCES IN THERAPY

IF4

2009-11-0439

PREAI